Report 27 aoû 2021 スイスの循環型経済 現在の直線型経済モデルは「take-make-waste」の原則に支配されています。その結果、生態系や天然資源への圧力が増しています。直線型経済モデルは、資源不足や資源の浪費を生み、最後には気候変動や生物多様性損失などの環境危機が生じます。人類は地球の限界(プラネタリー・バウンダリー)を超...
News 23 déc 2022 Investors give Resistell 8.5 million Swiss francs Resistell AG has secured 8.5 million Swiss francs in the first part of its series B funding round. The biotechnology company plans to use this to...
News 20 juil 2022 Forty51 closes first fund totaling 43 million US dollars A new Basel-based venture fund, Forty51 Ventures I, has raised a total of 43 million US dollars following a first fund closing. Forty51 invests i...
News 18 mai 2022 Aesara heading to the Greater Zurich Area Aesara is establishing a new branch office in the Greater Zurich Area this May. The North American market access agency sees becoming a part of t...
News 06 juil 2022 Qarad, part of the QbD Group, expands to Switzerland Belgian-based IVD specialist Qarad is your gateway to Europe for In Vitro Diagnostics and Medical Devices. The company has recently opened a new ...
Service ExportHelp We are the first point of contact for Swiss and Liechtenstein SMEs with regard to administrative export-related issues of all kinds.
Actualités 23 oct 2020 JSR Life Sciences va étendre les capacités de fabrication de produits biologiques de KBI Biopharma et Selexis à Genève Une nouvelle installation ultramoderne accueillera le fabricant de produits biologiques KBI Biopharma et le développeur de lignées cellulaires Se...
Actualités 01 fév 2022 Merck rachète la société biopharmaceutique genevoise Chord Therapeutics Chord Therapeutics, société biopharmaceutique de phase clinique qui développe des médicaments pour des maladies neuroinflammatoires rares, est ra...
News 30 mar 2021 “A machine that is more intelligent than a human being does not yet exist” Artificial intelligence is expected to create new economic possibilities. But what exactly are they, and how can they be developed? These are the...
ニュース 03 déc 2020 バーゼル地域のヘルステック活動 欧州最大のライフサイエンスクラスターとして知られるスイス・バーゼル地域。そのなかでもヘルステック分野に焦点を当て、バーゼル在住のライフサイエンスアナリスト平野まり子氏による2020年11月現在の動向レポートを掲載いたします。世界各国から様々な規模の企業が集まり、オープンイノベーションや協業...
Success stories 25 mai 2023 Yokogawa Innovation Switzerland: How microalgae open up new possibilities for food and medicine. Yokogawa Electric Corporation Microalgae open up new possibilities for food and medicine. From its base in Switzerland, the mission of YIS is to find promising biotechnology f...
News 26 jan 2022 Basel Area – exactly the right chemistry for South Korean pharma companies KPBMA and Basel Area Business & Innovation establish tailored collaboration to support Korean biopharmaceutical companies to enter the Europe...
News 01 fév 2022 Merck acquires Geneva-based biopharmaceutical company Chord Therapeutics Chord Therapeutics, a clinical stage biopharmaceutical company developing drugs for rare neuroinflammatory diseases, is being acquired by Merck.
News 12 jan 2022 ObsEva achieves positive results in the treatment of endometriosis Geneva-based women’s health biopharmaceutical company ObsEva has announced positive topline results from the Phase 3 EDELWEISS 3 trial of linzago...
Technologies et industries suisses Fabrication de pointe Forte d'un riche savoir-faire dans les secteurs de l’horlogerie, de la métallurgie et des machines-outils et des technologies médicales, la Suiss...
Actualités 30 juin 2021 La technologie du CSEM dans la première machine au monde à produire des tissus de peau humaine Développé en collaboration avec le CSEM, le denovoCast est la première machine automatisée au monde à produire des greffes de tissu cutané person...